Nuvectis Pharma, Inc./$NVCT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nuvectis Pharma, Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Ticker
$NVCT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
13
ISIN
US67080T1088
Website
NVCT Metrics
BasicAdvanced
$222M
-
-$1.12
-0.12
-
Price and volume
Market cap
$222M
Beta
-0.12
52-week high
$11.52
52-week low
$5.87
Average daily volume
151K
Financial strength
Current ratio
3.279
Quick ratio
3.248
Management effectiveness
Return on assets (TTM)
-52.69%
Return on equity (TTM)
-115.28%
Valuation
Price to book
10.61
Price to tangible book (TTM)
10.61
Price to free cash flow (TTM)
-14.008
Growth
Earnings per share change (TTM)
-19.93%
3-year earnings per share growth (CAGR)
-26.54%
NVCT News
AllArticlesVideos
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference
GlobeNewsWire·2 weeks ago
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
GlobeNewsWire·1 month ago
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nuvectis Pharma, Inc. stock?
Nuvectis Pharma, Inc. (NVCT) has a market cap of $222M as of May 31, 2025.
What is the P/E ratio for Nuvectis Pharma, Inc. stock?
The price to earnings (P/E) ratio for Nuvectis Pharma, Inc. (NVCT) stock is 0 as of May 31, 2025.
Does Nuvectis Pharma, Inc. stock pay dividends?
No, Nuvectis Pharma, Inc. (NVCT) stock does not pay dividends to its shareholders as of May 31, 2025.
When is the next Nuvectis Pharma, Inc. dividend payment date?
Nuvectis Pharma, Inc. (NVCT) stock does not pay dividends to its shareholders.
What is the beta indicator for Nuvectis Pharma, Inc.?
Nuvectis Pharma, Inc. (NVCT) has a beta rating of -0.12. This means that it has an inverse relation to market volatility.